Robert J Motzer (Robert Motzer, Susanna Hegewisch-Becker)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 78

Top Topics

Obsessive Compulsive Disorder

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation. Cancer immunology research 12 (3) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G Nair, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Gruenwald
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation. Cancer immunology research 12 (3) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Toni K Choueiri, Amber C Donahue, David A Braun, Brian I Rini, Thomas Powles, John B A G Haanen, James M G Larkin, Xinmeng Jasmine Mu, Jie Pu, Rosemary E Teresi, Alessandra di Pietro, Paul B Robbins, Robert J Motzer
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer discovery 14 (3) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Jack Patrick Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Brett S Carver, Manjit Bains, David R Jones, Dean F Bajorin, George J Bosl, Deaglan Joseph McHugh, Samuel A Funt, Robert J Motzer, Darren R Feldman
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Robert J Motzer, Guillermo Mendez, Joseph Chao, Radim Nemecek, Kynan Feeney, Eric Van Cutsem, Salah-Eddin Al-Batran, Wasat Mansoor, Nicholas Maisey, Roberto A Pazo-Cid, Matthew Burge, David Perez-Callejo, R William Hipkin, Sourav Mukherjee, Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J Kelly, Niall C Tebbutt
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. Journal for immunotherapy of cancer 12 (7) (2024)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation. Cancer immunology research 12 (3) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Samuel A Funt, Andrea Knezevic, Kaamilah Wilson, Maria Bromberg, Amy Budnick, Kerri L O'Connor, Deaglan Joseph McHugh, Erik Larsen, Dean F Bajorin, Robert J Motzer, Emily S Tonorezos, Sujata Patil, Darren R Feldman
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors. Cancer (2023)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation. Cancer immunology research (2023)
Robert J Motzer, Manuela Schmidinger, Masatoshi Eto, Cristina Suarez, Robert Figlin, Yanfang Liu, Rodolfo Perini, Yayan Zhang, Daniel Yc Heng
LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy. Future oncology (London, England) (2023)
Thomas Denize, Opeyemi A Jagede, Sayed Matar, Nourhan El Ahmar, Destiny J West, Emily Walton, Aseman Sheshdeh Bagheri, Varunika Savla, Yasmin Nabil Laimon, Saurabh Gupta, Sai Vikram Vemula, David A Braun, Kelly P Burke, Paul J Catalano, Gordon J Freeman, Robert J Motzer, Michael B Atkins, David F McDermott, Arlene H Sharpe, Toni K Choueiri, Sabina Signoretti
PD-1 Expression on Intratumoral Regulatory T Cells is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear Cell Renal Cell Carcinoma Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation. Cancer immunology research (2023)
Ritesh R Kotecha, Andrea Knezevic, Kanika S Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria Isabel Carlo, Kelly N Fitzgerald, Darren R Feldman, Neil J Shah, Ed Reznik, Abraham Ari Hakimi, Jian Carrot-Zhang, Diana L Mandelker, Michael F Berger, Chung-Han Lee, Robert J Motzer, Martin H Voss
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features. Cancer (2023)
Robert J Motzer, Saby George, Jaime R Merchan, Thomas E Hutson, Xun Song, Rodolfo F Perini, Ran Xie, Urmi Bapat, Javier Puente
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab. The oncologist (2023)
Arielle Elkrief, Nicholas R Waters, Natalie Smith, Angel Dai, John B Slingerland, Nathan Aleynick, Binita Febles, Pooja Gogia, Nicholas D Socci, Melissa A Lumish, Paul A Giardina, Jamie E Chaft, Juliana Eng, Robert J Motzer, Robin B Mendelsohn, Kate A Markey, Mingqiang Zhuang, Yanyun Li, Zhifan Yang, Travis J Hollman, Charles M Rudin, Marcel R M van den Brink, Jinru Shia, Susan DeWolf, Adam J Schoenfeld, Matthew D Hellmann, N Esther Babady, David M Faleck, Jonathan U Peled
Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation. Cancer immunology research (2023)
Thomas Denize, Yue Hou, Jean-Christophe Pignon, Emily Walton, Destiny J West, Gordon J Freeman, David A Braun, Catherine J Wu, Saurabh Gupta, Robert J Motzer, Michael B Atkins, David McDermott, Toni K Choueiri, Sachet A Shukla, Sabina Signoretti
Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Robert J Motzer, David F McDermott, Bernard Escudier, Mauricio Burotto, Toni K Choueiri, Hans J Hammers, Philippe Barthélémy, Elizabeth R Plimack, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Howard Gurney, Christian K Kollmannsberger, Marc-Oliver Grimm, Carlos Barrios, Yoshihiko Tomita, Daniel Castellano, Viktor Grünwald, Brian I Rini, M Brent McHenry, Chung-Wei Lee, Jennifer McCarthy, Flavia Ejzykowicz, Nizar M Tannir
Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma. Cancer 128 (11) (2022)
Yasser Ged, Alejandro Sanchez, Sujata Patil, Andrea Knezevic, Emily Stein, Stacey Petruzella, Kate Weiss, Cihan Duzgol, Joshua Chaim, Oguz Akin, Marina Mourtzakis, Michael T Paris, Jessica M Scott, Fengshen Kuo, Ritesh R Kotecha, Abraham Ari Hakimi, Chung-Han Lee, Robert J Motzer, Martin H Voss, Helena Furberg
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Phillip M Rappold, Lynda Vuong, Josef Leibold, Nicholas H Chakiryan, Michael Curry, Fengshen Kuo, Erich Sabio, Hui Jiang, Briana G Nixon, Ming Liu, Anders E Berglund, Andrew W Silagy, Eduardo A Mascareno, Mahdi Golkaram, Mahtab Marker, Albert Reising, Alexander Savchenko, John M Millholland, Ying-Bei Chen, Paul Russo, Jonathan A Coleman, Ed Reznik, Brandon J Manley, Irina Ostrovnaya, Vladimir Makarov, Renzo G DiNatale, Kyle A Blum, Xiaoxiao Ma, Diego Chowell, Ming O Li, David B Solit, Scott W Lowe, Timothy A Chan, Robert J Motzer, Martin H Voss, Abraham Ari Hakimi
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma. Cancer discovery 12 (10) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Ritesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, Andrea Knezevic, Samuel Murray, Ian Johnson, Natalie Shapnik, Darren R Feldman, Maria Isabel Carlo, Neil J Shah, Marisa Dunigan, Kety Huberman, Ryma Benayed, Ahmet Zehir, Michael F Berger, Marc Ladanyi, Dana Wai Yi Tsui, Robert J Motzer, Chung-Han Lee, Martin H Voss
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. JCO precision oncology 6 (2022)
Chung-Han Lee, Martin H Voss, Maria Isabel Carlo, Ying-Bei Chen, Mark Zucker, Andrea Knezevic, Robert A Lefkowitz, Natalie Shapnik, Chloe Dadoun, Ed Reznik, Neil J Shah, Colette Ngozi Owens, Deaglan Joseph McHugh, David Henry Aggen, Andrew Leonard Laccetti, Ritesh R Kotecha, Darren R Feldman, Robert J Motzer
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, Luisa Victoria Silva, Lakshmi Chilukuri, Sokratis A Apostolidis, Alexander C Huang, Alexander Muselman, Sasikanth Manne, Oliva Kuthuru, Ryan P Staupe, Sharon A Adamski, Senthil Kannan, Raj K Kurupati, Hildegund C J Ertl, Jeffrey L Wong, Stylianos Bournazos, Suzanne McGettigan, Lynn M Schuchter, Ritesh R Kotecha, Samuel A Funt, Martin H Voss, Robert J Motzer, Chung-Han Lee, Dean F Bajorin, Tara C Mitchell, Jeffrey V Ravetch, E John Wherry
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nature immunology 23 (8) (2022)
Robert J Motzer, Toni K Choueiri, David F McDermott, Thomas Powles, Yann-Alexandre Vano, Saurabh Gupta, Jin Yao, Celine Han, Ron Ammar, Simon Papillon-Cavanagh, Shruti S Saggi, M Brent McHenry, Petra Ross-MacDonald, Megan Wind-Rotolo
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for immunotherapy of cancer 10 (3) (2022)
Robert J Motzer, Jean-François Martini, Xinmeng J Mu, Michael D Staehler, Daniel J George, Olga Valota, Xun Lin, Hardev S Pandha, Keith A Ching, Alain Ravaud
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. Nature communications 13 (1) (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Kelly N Fitzgerald, Robert J Motzer, Chung-Han Lee
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade. Nature reviews. Urology (2022)
Brian I Rini, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S Tykodi, Sumanta Kumar Pal, Saurabh Gupta, Chung-Wei Lee, Ruiyun Jiang, Nizar M Tannir
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma. Journal for immunotherapy of cancer 10 (12) (2022)
Chung-Han Lee, Robert J Motzer, Hamid Emamekhoo, Marc Matrana, Ivor J Percent, James J Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Montaser Shaheen, Johanna Bendell, Alice C Fan, Benjamin A Gartrell, Oscar B Goodman, Petros G Nikolinakos, Arash Rezazadeh Kalebasty, Yousef Zakharia, Zhentao Zhang, Hema Parmar, Lalith Akella, Keith Orford, Nizar M Tannir
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Toni K Choueiri, Harriet Kluger, Saby George, Scott S Tykodi, Timothy M Kuzel, Ruth Perets, Suresh Nair, Giuseppe Procopio, Michael A Carducci, Vincent Castonguay, Edmund Folefac, Chung-Han Lee, Sebastien J Hotte, Wilson H Miller, Shruti Shally Saggi, Chung-Wei Lee, Heshani Desilva, Prabhu Bhagavatheeswaran, Robert J Motzer, Bernard Escudier
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy. Journal for immunotherapy of cancer 10 (11) (2022)
Brian I Rini, Javid J Moslehi, Marc Bonaca, Manuela Schmidinger, Laurence Albiges, Toni K Choueiri, Robert J Motzer, Michael B Atkins, John B A G Haanen, Mariangela Mariani, Jing Wang, Subramanian Hariharan, James M G Larkin
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Kyrollis Attalla, Renzo G DiNatale, Phillip M Rappold, Christopher J Fong, Francisco Sanchez-Vega, Andrew W Silagy, Stanley Weng, Jonathan Coleman, Chung-Han Lee, Maria Isabel Carlo, Jeremy C Durack, Stephen B Solomon, Victor E Reuter, Paul Russo, Timothy A Chan, Robert J Motzer, Nikolaus D Schultz, Ed Reznik, Martin H Voss, A Ari Hakimi
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Jack Patrick Gleeson, Ines Nikolovski, Renzo Dinatale, Mark Zucker, Andrea Knezevic, Sujata Patil, Yasser Ged, Ritesh R Kotecha, Natalie Shapnik, Samuel Murray, Paul Russo, Jonathan Coleman, Chung Han Lee, Zsofia K Stadler, A Ari Hakimi, Darren R Feldman, Robert J Motzer, Ed Reznik, Martin H Voss, Ying-Bei Chen, Maria Isabel Carlo
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Meredith M Regan, Opeyemi A Jagede, Charlene M Mantia, Thomas Powles, Lillian Werner, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Elizabeth R Plimack, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albiges, Stephen Huo, Viviana Del Tejo, Brian Stwalley, Michael B Atkins, David F McDermott
Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Robert J Motzer, Bernard Escudier, David F McDermott, Osvaldo Arén Frontera, Bohuslav Melichar, Thomas Powles, Frede Donskov, Elizabeth R Plimack, Philippe Barthélémy, Hans J Hammers, Saby George, Viktor Grünwald, Camillo Porta, Victoria Neiman, Alain Ravaud, Toni K Choueiri, Brian I Rini, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Marc-Oliver Grimm, Howard Gurney, Raya Leibowitz-Amit, Poul F Geertsen, Asim Amin, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial. Journal for immunotherapy of cancer 8 (2) (2021)
Chung-Han Lee, Renzo G DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero, Lynda Vuong, Mark Lee, Kate Weiss, Doug Hoen, Luc Morris, Ed Reznik, Samuel Murray, Ritesh R Kotecha, Martin H Voss, Maria Isabel Carlo, Darren R Feldman, Pallavi Sachdev, Yusuke Adachi, Yukinori Minoshima, Junji Matsui, Yasuhiro Funahashi, Kenichi Nomoto, A Ari Hakimi, Robert J Motzer, Timothy A Chan
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab. Molecular cancer research : MCR 19 (9) (2021)
Andrew W Silagy, Ritesh R Kotecha, Stanley Weng, Arturo Holmes, Nirmish Singla, Roy Mano, Kyrollis Attalla, Kate L Weiss, Renzo G DiNatale, Sujata Patil, Jonathan A Coleman, Robert J Motzer, Paul Russo, Martin H Voss, A Ari Hakimi
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. Cancer 127 (21) (2021)
Yasser Ged, Joshua L Chaim, Renzo G DiNatale, Andrea Knezevic, Ritesh R Kotecha, Maria I Carlo, Chung-Han Lee, Ashley Foster, Darren R Feldman, Min Yuen Teo, Gopakumar Iyer, Timothy Chan, Sujata Patil, Robert J Motzer, A Ari Hakimi, Martin H Voss
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. Journal for immunotherapy of cancer 8 (1) (2021)
Abraham Ari Hakimi, Kyrollis Attalla, Renzo G DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A Blum, Yasser Ged, Douglas Hoen, Sviatoslav M Kendall, Ed Reznik, Anita Bowman, Jason Hwee, Christopher J Fong, Fengshen Kuo, Martin H Voss, Timothy A Chan, Robert J Motzer
A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response. Nature communications 11 (1) (2020)
Michael B Atkins, Brian I Rini, Robert J Motzer, Thomas Powles, David F McDermott, Cristina Suarez, Sergio Bracarda, Walter M Stadler, Frede Donskov, Howard Gurney, Stephane Oudard, Motohide Uemura, Elaine T Lam, Carsten Grüllich, Susheela Carroll, Beiying Ding, Qian Cindy Zhu, Elisabeth Piault-Louis, Christina Schiff, Bernard Escudier
Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Abdallah Flaifel, Jean-Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R Harrison, Philippe Barthélémy, Scott S Tykodi, Judit Kocsis, Alain Ravaud, Jeronimo R Rodriguez-Cid, Sumanta K Pal, Andre M Murad, Yuko Ishii, Shruti Shally Saggi, M Brent McHenry, Brian I Rini
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Miriam Ficial, Opeyemi A Jagede, Miriam Sant'Angelo, Yue Hou, Abdallah Flaifel, Jean-Christophe Pignon, David A Braun, Megan Wind-Rotolo, Maura A Sticco-Ivins, Paul J Catalano, Gordon J Freeman, Arlene H Sharpe, F Stephen Hodi, Robert J Motzer, Catherine J Wu, Michael B Atkins, David F McDermott, Sachet A Shukla, Toni K Choueiri, Sabina Signoretti
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Anup Patel, Alain Ravaud, Robert J Motzer, Michael Staehler, Bernard Escudier, Jean-Francois Martini, Mariajose Lechuga, Xun Lin, Daniel J George
Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Robert J Motzer, Bernard Escudier, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Elizabeth R Plimack, Giuseppe Procopio, David F McDermott, Daniel Castellano, Toni K Choueiri, Frede Donskov, Howard Gurney, Stéphane Oudard, Martin Richardet, Katriina Peltola, Ajjai S Alva, Michael Carducci, John Wagstaff, Christine Chevreau, Satoshi Fukasawa, Yoshihiko Tomita, Thomas C Gauler, Christian K Kollmannsberger, Fabio A Schutz, James Larkin, David Cella, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. Cancer 126 (18) (2020)
Darren R Feldman, Yasser Ged, Chung-Han Lee, Andrea Knezevic, Ana M Molina, Ying-Bei Chen, Joshua Chaim, Devyn T Coskey, Samuel Murray, Satish K Tickoo, Victor E Reuter, Sujata Patil, Han Xiao, Jahan Aghalar, Arlyn J Apollo, Maria I Carlo, Robert J Motzer, Martin H Voss
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Cancer 126 (24) (2020)
Julian Marcon, Renzo G DiNatale, Alejandro Sanchez, Ritesh R Kotecha, Sounak Gupta, Fengshen Kuo, Vladimir Makarov, Amar Sandhu, Roy Mano, Andrew W Silagy, Kyle A Blum, Daniel E Nassau, Nicole E Benfante, Michael V Ortiz, Maria Isabel Carlo, Timothy A Chan, Robert J Motzer, Martin H Voss, Jonathan Coleman, Paul Russo, Victor Reuter, A Ari Hakimi, Ed Reznik
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Robert J Motzer, Paul B Robbins, Thomas Powles, Laurence Albiges, John B A G Haanen, James Larkin, Xinmeng Jasmine Mu, Keith A Ching, Motohide Uemura, Sumanta K Pal, Boris Alekseev, Gwenaelle Gravis, Matthew T Campbell, Konstantin Penkov, Jae Lyun Lee, Subramanian Hariharan, Xiao Wang, Weidong Zhang, Jing Wang, Aleksander Chudnovsky, Alessandra di Pietro, Amber C Donahue, Toni K Choueiri
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nature medicine 26 (11) (2020)
Kyle A Blum, Sounak Gupta, Satish K Tickoo, Timothy A Chan, Paul Russo, Robert J Motzer, Jose A Karam, Abraham Ari Hakimi
Sarcomatoid renal cell carcinoma: biology, natural history and management. Nature reviews. Urology 17 (12) (2020)
Angelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson, Sarah Sally J Lord, Val Gebski, Stephen Clarke, Paul de Souza, Robert J Motzer, Chee Khoon Lee
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy. Acta oncologica (Stockholm, Sweden) 59 (1) (2019)
Chung-Han Lee, Robert J Motzer
Combination therapy for advanced and metastatic kidney cancer. Nature reviews. Urology 16 (2) (2019)
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro, Thomas J Kaley, Sviatoslav M Kendall, Robert J Motzer, A Ari Hakimi, Martin H Voss, Paul Russo, Jonathan Rosenberg, Gopakumar V Iyer, Bernard H Bochner, Dean F Bajorin, Hikmat A Al-Ahmadie, Jamie E Chaft, Charles M Rudin, Gregory J Riely, Shrujal Baxi, Alan L Ho, Richard J Wong, David G Pfister, Jedd D Wolchok, Christopher A Barker, Philip H Gutin, Cameron W Brennan, Viviane Tabar, Ingo K Mellinghoff, Lisa M DeAngelis, Charlotte E Ariyan, Nancy Lee, William D Tap, Mrinal M Gounder, Sandra P D'Angelo, Leonard Saltz, Zsofia K Stadler, Howard I Scher, Jose Baselga, Pedram Razavi, Christopher A Klebanoff, Rona Yaeger, Neil H Segal, Geoffrey Y Ku, Ronald P DeMatteo, Marc Ladanyi, Naiyer A Rizvi, Michael F Berger, Nadeem Riaz, David B Solit, Timothy A Chan, Luc G T Morris
Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nature genetics 51 (2) (2019)
A Ari Hakimi, Martin H Voss, Fengshen Kuo, Alejandro Sanchez, Ming Liu, Briana G Nixon, Lynda Vuong, Irina Ostrovnaya, Ying-Bei Chen, Victor Reuter, Nadeem Riaz, Yuan Cheng, Parul Patel, Mahtab Marker, Albert Reising, Ming O Li, Timothy A Chan, Robert J Motzer
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial. Cancer discovery 9 (4) (2019)
Abdallah Flaifel, Wanling Xie, David A Braun, Miriam Ficial, Ziad Bakouny, Amin H Nassar, Rebecca B Jennings, Bernard Escudier, Daniel J George, Robert J Motzer, Michael J Morris, Thomas Powles, Evelyn Wang, Ying Huang, Gordon J Freeman, Toni K Choueiri, Sabina Signoretti
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (20) (2019)
Ritesh R Kotecha, Robert J Motzer, Martin H Voss
Towards individualized therapy for metastatic renal cell carcinoma. Nature reviews. Clinical oncology 16 (10) (2019)
Diana Miao, Claire A Margolis, Wenhua Gao, Martin H Voss, Wei Li, Dylan J Martini, Craig Norton, Dominick Bosse, Stephanie M Wankowicz, Dana Cullen, Christine Horak, Megan Wind-Rotolo, Adam Tracy, Marios Giannakis, Frank Stephen Hodi, Charles G Drake, Mark W. Ball, Mohamad E Allaf, Alexandra Snyder, Matthew D Hellmann, Thai H Ho, Robert J Motzer, Sabina Signoretti, William G Kaelin, Toni K Choueiri, Eliezer Van Allen
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science (New York, N.Y.) 359 (6377) (2018)
Rana R McKay, Dominick Bosse, Wanling Xie, Stephanie A M Wankowicz, Abdallah Flaifel, Raphael Brandao, Aly-Khan A Lalani, Dylan J Martini, Xiao X Wei, David A Braun, Eliezer Van Allen, Daniel Castellano, Guillermo De Velasco, J Connor Wells, Daniel Y Heng, Andre P Fay, Fabio A Schutz, JoAnn Hsu, Sumanta K Pal, Jae Lyun Lee, James J Hsieh, Lauren C Harshman, Sabina Signoretti, Robert J Motzer, Darren Feldman, Toni K Choueiri
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma. Cancer immunology research 6 (7) (2018)
Daniel J George, Jean-Francois Martini, Michael Staehler, Robert J Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J Pantuck, Hardev S Pandha, Anup Patel, Maria Lechuga, Alain Ravaud
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (4) (2018)
John A Thompson, Robert J Motzer, Ana M Molina, Toni K Choueiri, Elisabeth I Heath, Bruce G Redman, Randeep S Sangha, D Scott Ernst, Roberto Pili, Stella K Kim, Leonard Reyno, Aya Wiseman, Fabio Trave, Banmeet Anand, Karen Morrison, Fernando Doñate, Christian K Kollmannsberger
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (18) (2018)
Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae-Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Hwa Chang, Arun Azad, Ian D Davis, Marlene J Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert J Motzer
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial. Journal of hematology & oncology 11 (1) (2018)
Martin H Voss, Ying-Bei Chen, Albert Reising, Mahtab Marker, Jiayuan Shi, Jianning Xu, Irina Ostrovnaya, Venkatraman E Seshan, Almedina Redzematovic, Parul Patel, Xia Han, James J Hsieh, A Ari Hakimi, Robert J Motzer
PTEN Expression, Not Mutation Status in TSC1, TSC2, or mTOR, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (2) (2018)